KIAA1267 inhibitors represent a class of compounds that interact with the KIAA1267 protein, a relatively underexplored yet significant target in molecular biology. KIAA1267 is a large, multi-domain protein encoded by the KIAA1267 gene, also known by its more recently assigned name, DLGAP5 (Discs Large Homolog-Associated Protein 5). This protein is involved in key regulatory processes in cellular dynamics, particularly in the regulation of the mitotic spindle apparatus, which is essential for proper cell division. Inhibitors of KIAA1267 target the functional domains of this protein, altering its ability to engage in protein-protein interactions that are crucial for mitotic progression. The specific inhibition of KIAA1267 can have a profound impact on cellular mechanics, leading to effects such as mitotic arrest or altered spindle checkpoint responses. Understanding the molecular mechanisms by which KIAA1267 inhibitors exert these changes offers valuable insights into cell cycle regulation and protein interaction networks.
From a chemical standpoint, KIAA1267 inhibitors often feature structural motifs designed to bind selectively to the protein's interaction domains. These motifs typically disrupt the binding interface between KIAA1267 and other key mitotic regulatory proteins. The development of these inhibitors involves extensive computational modeling to predict how chemical structures interact with the KIAA1267 protein at the atomic level. Structural biology techniques, such as X-ray crystallography or cryo-electron microscopy, are employed to elucidate the precise binding modes of these inhibitors. Once bound, the inhibitors either stabilize or destabilize the KIAA1267 complex, depending on their mechanism of action. By interfering with KIAA1267's role in cellular division, these inhibitors serve as crucial molecular tools for investigating the biochemical pathways that control mitosis and, more broadly, cellular proliferation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Raltegravir | 518048-05-0 | sc-364600 sc-364600A sc-364600B sc-364600C sc-364600D | 5 mg 50 mg 100 mg 500 mg 1 g | $100.00 $821.00 $1229.00 $2861.00 $4085.00 | 21 | |
An HIV integrase inhibitor that indirectly affects LEDGF function by inhibiting the integration of HIV DNA. | ||||||
S/GSK1349572 | 1051375-16-6 | sc-364605 sc-364605B sc-364605A | 5 mg 50 mg 200 mg | $367.00 $1484.00 $4131.00 | ||
A third HIV integrase inhibitor, indirectly influencing LEDGF activity in the HIV life cycle. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $242.00 $871.00 | 1 | |
A broad CDK inhibitor, including CDK9, potentially affecting LEDGF-associated transcription processes. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Another CDK inhibitor with potential indirect effects on LEDGF through transcription regulation. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $148.00 $515.00 | 8 | |
Inhibits PLK1, a kinase involved in cell cycle regulation, potentially influencing LEDGF's cellular roles. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
PARP inhibitor, could indirectly affect LEDGF's role in DNA repair pathways. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Another PARP inhibitor, indirectly influencing LEDGF's involvement in DNA repair. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
A PARP inhibitor, potentially affecting LEDGF-related DNA repair mechanisms. | ||||||
Talazoparib | 1207456-01-6 | sc-507440 | 10 mg | $795.00 | ||
PARP inhibitor, might indirectly influence LEDGF's function in DNA repair pathways. | ||||||